Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

APRE

Aprea Therapeutics (APRE)

Aprea Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:APRE
日付受信時刻ニュースソース見出しコード企業名
2024/05/1421 : 40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2024/05/1421 : 35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
2024/02/0707 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2024/02/0514 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APREAprea Therapeutics Inc
2024/02/0306 : 26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2024/01/2621 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2024/01/2620 : 03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APREAprea Therapeutics Inc
2024/01/0506 : 16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/11/1006 : 20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APREAprea Therapeutics Inc
2023/11/1006 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/11/1006 : 10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
2023/10/1706 : 29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/10/1320 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/09/1121 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/08/2510 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
2023/08/2510 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
2023/08/2510 : 48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
2023/08/2421 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/08/1020 : 39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
2023/08/1020 : 36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/07/1120 : 40Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:APREAprea Therapeutics Inc
2023/07/1120 : 30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APREAprea Therapeutics Inc
2023/07/0605 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/06/1421 : 00GlobeNewswire Inc.Aprea Therapeutics to Present at Maxim Virtual Healthcare ConferenceNASDAQ:APREAprea Therapeutics Inc
2023/06/0905 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APREAprea Therapeutics Inc
2023/05/3021 : 30GlobeNewswire Inc.Aprea Therapeutics to Present at BIO International ConventionNASDAQ:APREAprea Therapeutics Inc
2023/05/1605 : 48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APREAprea Therapeutics Inc
2023/05/1605 : 40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APREAprea Therapeutics Inc
2023/05/1605 : 05GlobeNewswire Inc.Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business OperationsNASDAQ:APREAprea Therapeutics Inc
2023/05/0906 : 16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APREAprea Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APRE

最近閲覧した銘柄

Delayed Upgrade Clock